Profound vs Thermo Fisher Scientific

Side-by-side comparison of AI visibility scores, market position, and capabilities

AI visibility is closely matched (79 vs 79)
Profound logo

Profound

Leaderhealthcare

AI medical imaging

FDA-cleared AI breast cancer detection suite by iCAD (acquired by RadNet 2025). ProFound AI reads 40M+ mammograms globally with 23% improved detection rate.

AI VisibilityBeta
Overall Score
B79
Category Rank
#27 of 596
AI Consensus
75%
Trend
up
Per Platform
ChatGPT
74
Perplexity
84
Gemini
81

About

Profound AI is the medical imaging AI brand developed by iCAD, a pioneer in cancer detection technology. iCAD's ProFound AI platform applies deep learning to mammography analysis, providing radiologists with AI-powered decision support that identifies suspicious lesions, calculates cancer risk scores, and prioritizes reading worklists based on AI-assessed urgency. The system is designed to function as a second reader — augmenting rather than replacing radiologist judgment — by flagging findings that warrant closer attention and reducing the cognitive load on radiologists reviewing high volumes of routine screening mammograms.\n\nProFound AI has achieved FDA clearance as a medical device for breast cancer detection, enabling its use in clinical radiology workflows across US health systems. The platform processes mammograms in real time, integrating with existing PACS and radiology information systems so it can be deployed without disrupting established workflow. Its clinical validation studies have demonstrated a 23% improvement in cancer detection rate compared to unassisted reads, while simultaneously reducing false positives — a combination that is clinically meaningful and commercially compelling for radiology practices seeking to improve outcomes without adding radiologist time.\n\nProFound AI reads over 40 million mammograms globally, making it one of the most widely deployed FDA-cleared AI systems in radiology. iCAD was acquired by RadNet in 2025, integrating ProFound into one of the largest radiology network operators in the United States. This acquisition significantly expands ProFound's deployment footprint, as RadNet operates hundreds of imaging centers across the US and has the scale to make AI-assisted mammography a standard-of-care offering. The combination of FDA clearance, proven clinical performance, massive global deployment, and integration into a major radiology network positions ProFound AI as a market-defining product in cancer detection AI.

Full profile
Thermo Fisher Scientific logo

Thermo Fisher Scientific

LeaderHealthcare Tech

Enterprise

Thermo Fisher (TMO) reported $42.9B revenue in FY2024, down 1% YoY. World's #1 life sciences company. Serves pharma, biotech, labs globally. ~100,000 employees. HQ: Waltham, MA.

AI VisibilityBeta
Overall Score
B79
Category Rank
#24 of 596
AI Consensus
80%
Trend
stable
Per Platform
ChatGPT
81
Perplexity
79
Gemini
85

About

Thermo Fisher Scientific Inc. is the world's largest life sciences company, providing analytical instruments, reagents, consumables, software, and services to researchers, healthcare organizations, and industrial companies. Headquartered in Waltham, Massachusetts, Thermo Fisher was formed through the 2006 merger of Thermo Electron and Fisher Scientific and has since grown aggressively through acquisitions. The company reported revenues of $42.9B in FY2024, slightly down year-over-year after exceptional COVID-related revenue in 2021–2022.

Full profile

AI Visibility Head-to-Head

79
Overall Score
79
#27
Category Rank
#24
75
AI Consensus
80
up
Trend
stable
74
ChatGPT
81
84
Perplexity
79
81
Gemini
85
81
Claude
77
84
Grok
77

Key Details

Category
AI medical imaging
Enterprise
Tier
Leader
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Profound
AI medical imaging

Integrations

Only Thermo Fisher Scientific
Thermo Fisher Scientific is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.